Pakistan Journal of Pharmaceutical Sciences

巴基斯坦药学杂志（PJPS）是一个同行评审的多学科药学杂志。PJPS起源于1988年，由卡拉奇大学药学系出版，每两年出版一次，2005年每季度出版一次，现在从2013年1月开始，PJPS每两个月出版一次。PJPS涵盖生物、药物和药物研究（药物递送、药物管理、分子生物学、生物化学、药理学、药代动力学、植物化学、生物分析、治疗学、生物技术和纳米颗粒研究）。PJPS在ASCI数据库，亚洲网，CAB摘要，CABI，化学文摘，EBSCO，EMBASE，EMRmedex，ESSCI，EVISA，GDPBM，Genamics，IMEMR，IndexCopernicus，IndexPharmacus，ISI，JournalSeek，MEDLINE / PubMed，NLM中进行抽象和/或索引。 LocatorPlus，PakMediNet，PASTIC，PMRC，Pubget，ResearchGATE，SADCCT，SCIENCE Pakistan，SCImago，SCOPUS，Scribd，Serial Cited，SID，WebStatDomain和WorldCat。巴基斯坦药学杂志是巴基斯坦化学、生物学和医学界的期刊。它出版了来自世界各地的作者的医药科学各个领域的原始研究和评论文章。它的使命是整合广泛而繁荣的医药科学领域。PJPS被高等教育委员会认定为“W”类，2011年被汤姆森·鲁特授予影响系数1.103。

Pakistan Journal of Pharmaceutical Sciences (PJPS) is a peer reviewed multi-disciplinary pharmaceutical sciences journal. The PJPS had its origin in 1988 from the Faculty of Pharmacy, University of Karachi as a biannual journal, frequency converted as quarterly in 2005, and now PJPS is being published as bi-monthly from January 2013.PJPS covers Biological, Pharmaceutical and Medicinal Research (Drug Delivery, Pharmacy Management, Molecular Biology, Biochemical, Pharmacology, Pharmacokinetics, Phytochemical, Bio-analytical, Therapeutics, Biotechnology and research on nano particles.PJPS is abstracted and/or indexed in ASCI Database, AsiaNet, CAB Abstracts, CABI, Chemical Abstracts, EBSCO, EMBASE, EMRmedex, ESSCI, EVISA, GDPBM, Genamics, IMEMR, IndexCopernicus, IndexPharmacus, ISI, JournalSeek, MEDLINE/PubMed, NLM LocatorPlus, PakMediNet, PASTIC, PMRC, Pubget, ResearchGATE, SADCCT, SCIENCE Pakistan, SCImago, SCOPUS, Scribd, Serial Cited, SID, WebStatDomain and WorldCat. Pakistan Journal of Pharmaceutical Sciences is Pakistani journal at the interface of chemistry, biology and medicine. It publishes original research and review articles from all fields of Pharmaceutical Sciences from authors all over the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences. PJPS is recognized by Higher Education Commission with “W” category and awarded Impact Factor 1.103 by Thomson Reuter in 2011.